The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

A world-first vaccine for the vomiting bug norovirus is being trialled in the UK, with the hope it could cut the “burden on ...

“Common symptoms of norovirus include nausea, diarrhoea, and vomiting,” says Sharma. “In some cases, individuals may also ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

A norovirus vaccine based on the mRNA technology that helped to defeat Covid will be trialled in the UK for the first time, ...

It is hoped a study will show the jab is effective against the highly infectious disease which puts the NHS under "huge ...

In one of our recent articles about 10 High Growth Non-Tech Stocks That Are Profitable in 2024, we talked about how the US ...